Developmental Biology: In the article "Spatial and temporal pattern of expression of the cellular retinoic acid-binding protein and the cellular retinol-binding protein during mouse embryogenesis" by Ana V. Perez-Castro, Leslie E. TothRogler, Li-na Wei, and M. Chi Nguyen-Huu, which appeared in number 22, November 1989, ofProc. NatI. Acad. Sci. USA (86,(8813)(8814)(8815)(8816)(8817) 
in number 22 , November 1989, ofProc. NatI. Acad. Sci. USA (86, (8813) (8814) (8815) (8816) (8817) , the following printer's error should be noted. The grey background was not removed as directed from color figures 1 (Upper Left) Bright-field photomicrograph on which arrows specify certain areas: tel, telecephalon; mes, mesencephalon; mye, myelencephalon; sc, spinal cord; drg, dorsal root ganglia; sn, spinal nerves; h, heart; t, tongue; Iv, liver; da, dorsal aorta. (u) In the eye, CRABP is expressed in the retinal layer, and CRBP is expressed in both retinal and pigmented layers. (uii) In the craniofacial region, CRABP transcripts were found in the mesenchyme of the frontonasal mass and mandible, while CRBP transcripts were found in the mesenchyme of the nasolachrymal duct and surrounding the auditory vesicle. Two general conclusions can be made. First, all of the tissues that are known to be teratogenic targets of retinoic acid and retinol also express CRABP and CRBP transcripts. Second, the specific expression of CRABP and CRBP in numerous developing tissues indicates that these proteins may perform specific functions during morphogenesis of a broad variety of embryonic structures.
The retinoids exert profound effects on development and differentiation in a wide variety of systems (1) (2) (3) (4) (5) (6) (7) . In the developing chick limb, retinoic acid has the ability to change the positional information of cells in a very precise manner: for example, application of retinoic acid to the side opposite the zone of polarizing activity causes digit pattern duplication (8, 9) . Retinoid treatment of chicken embryos affects the development of the upper beak by inhibiting the outgrowth and differentiation of the frontonasal mass (10) .
In mammals, it is known that maternal hypervitaminosis A is responsible for a variety of congenital malformations (11) . In mouse embryos, it has been reported that hypervitaminosis A causes alterations in the cell cycle of neuroepithelial cells and prevents the closure of the neural tube, producing brain deformities (12, 13) . Excess vitamin A also alters the pattern of migration of cranial neural crest cells, producing facial skeleton deformities (cleft palate) (14, 15) . Alterations in the cephalic mesoderm, the axial nonsegmented mesoderm, and finally the segmented mesoderm, especially the somites (rib defects and vertebral malformations), are also caused by administration of excess vitamin A (16, 17) . In humans, maternal exposure to isotretinoin (Accutane), a retinoid derivative, has been reported to produce several malformations including craniofacial deformities (18) . The teratogenic effects of exogenous retinoic acid may reflect a possible role for this compound as an endogenous morphogen in development. Indeed, retinoic acid has been detected in the developing chick limb forming a gradient across the bud (19) .
The molecular mechanisms by which retinoids affect morphogenesis are not understood. It is possible that their action is mediated by some of the known intracellular proteins that specifically bind retinoic acid or retinol. There exist an intracellular protein that binds retinoic acid, the cellular retinoic acid-binding protein (CRABP), and an intracellular protein that binds retinol, the cellular retinol-binding protein (CRBP) (20, 21) . Nuclear retinoic acid receptors have also been described: the nuclear retinoic acid receptors a and P (22, 23) . These nuclear receptors act as transcriptional activators in a retinoic acid-dependent manner. It has been proposed that CRABP and the nuclear retinoic acid receptors may cooperate in the mechanism of action of retinoic acid (24) . Interestingly, CRABP has been detected in the developing chicken limb and forms a gradient that is opposite in direction to the gradient formed by retinoic acid (25) .
As a step towards understanding the function of CRABP and CRBP in embryogenesis, we have used in situ hybridization to define the pattern of expression of these two genes. Our data show that CRABP and CRBP transcripts accumulate in specific temporal and spatial patterns, indicating a specific function for these genes during morphogenesis.
MATERIALS AND METHODS Plasmids. The plasmids pLNWX and pLNWY were constructed by subcloning in both orientations (sense and antisense) a 400-base-pair (bp) Alu I-Alu I fragment containing exon 1 of the mouse CRABP gene into the EcoRI site of pGem-2. The complete mouse CRABP gene has been isolated in our laboratory as a cosmid and contains four exons (unpublished data; refs. 26 and 27) . The 
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postcoitum (p.c.). Embryos were isolated at different days of gestation: 3.5, 7.5, 8.5, 9.5, 10.5, 11.5, 12.5, 14.5 days p.c. and fixed for 24 hr in 4% paraformaldehyde in phosphatebuffered saline (PBS) at 40C. After fixation the embryos were placed in 0.5 M sucrose in PBS at 40C for 24 hr and embedded in OTC compound (Miles). Sections were cut (8-10 Am) and placed on poly(L-lysine)-coated slides and stored at -70'C.
Preparation of Single-Stranded RNA Probes. pLNWX and pLNWY were linearized with HindIII, whereas pG2AVP was linearized in two different ways: for the sense probe (same sequence as transcript) with Pst I and for the antisense probe (sequence complementary to transcript) with EcoRI.
35S-labeled probes with a specific activity of 1-2 x 109 cpm/pug were prepared for plasmids pLNWX (sense CRABP probe), pLNWY (antisense CRABP probe), and pG2AVP linearized with Pst I by using Sp6 RNA polymerase (sense CRBP probe) and for pG2AVP linearized with EcoRI by using T7 RNA polymerase (antisense CRBP probe).
In Situ Hybridization. In situ hybridization was performed as described (29) . After dipping the slides in photographic emulsion NTB-2 (Kodak), they were exposed for 1-2 weeks, developed, and stained with Harris's hematoxylin/eosin. RESULTS Spatial Expression of CRABP and CRBP Transcripts. To determine if CRABP is expressed during mouse embryogenesis, we performed in situ hybridization initially with frontal sections of a 10.5-day embryo. In the representative section shown in Fig. 1 , CRABP transcripts are found in the limb bud (lb), the frontonasal mass (fnm), and the spinal cord (sc) and myelencephalon (mye). In the limb bud, a gradient pattern was observed along the anteroposterior axis, with the highest concentration at the anterior side. Thus, the CRABP transcript distribution in the limb is similar to the CRABP protein distribution reported by Maden et al. (25) . In the frontonasal mass, expression was seen in the mesenchymal cells but not in the epithelial cells. In the spinal cord and myelencephalon, expression was seen in the mantle layer but not in the ependymal layer. Furthermore, expression in the spinal cord was restricted mainly to the dorsal part.
To extend the CRABP data obtained with 10.5-day embryos and to determine whether CRBP is also expressed, we hybridized a series of adjacent sagittal sections of an 11.5-day mouse embryo and with either the CRABP or the CRBP probe (Fig. 2 Upper). The CRABP pattern observed was entirely consistent with the results presented in Fig. 1 . Moreover, we detected CRABP transcripts in additional places such as the mandible, the mesencephalon, the liver, the heart ventricle, the tongue, and the cells surrounding the dorsal aorta. Expression around the dorsal aorta seemed to be confined to the surrounding mesoderm and not to endothelial cells (see Fig. 4 c and c') . Fig. 2 shows that CRBP transcripts were also present in a defined pattern. Intense hybridization was seen in the ventral part of the spinal cord, the tongue, the liver, and around the stomach (Fig. 2 Upper) . Hybridization grains were also seen in the lung, around the large intestine, and the Wolffian and Mullerian ducts (data not shown). Hybridization was further detected in the dorsal root ganglia of the cervical region, in some cranial ganglia, and in the spinal nerves (see Fig. 4fand f'). However, the intensity of hybridization in the ganglia was weaker than in the spinal cord. Hybridization grains were also abundant in the telencephalon, the myelencephalon, and the mesenchyme surrounding the auditory and optic vesicles.
To extend these observations, we further analyzed transverse sections of a 12.5-day mouse embryo (Fig. 2 Lower). The patterns of both CRABP and CRBP transcripts showed good correlation with the patterns already described for the 10.5-and 11.5-day embryos. In the limb bud, CRABP transcripts were found in the lateral mesenchyme but not in the medial mesenchyme. In addition, a proximodistal gradient can be observed, with the highest concentration at the proximal side.
Expression in the Central Nervous System (CNS) Is Cell
Specific. The data in Figs. 1 and 2 show that expression of CRABP and CRBP in the CNS is specific to certain cell types. Therefore, we examined our sections under a high-power microscope (Fig. 3) .
In the spinal cord, CRABP was expressed in the dorsally located alar plates and in the intermediate horn, specifically in the mantle layer (Fig. 3 a and a' ). On the other hand, CRBP was expressed in the ependymal and mantle layers of the ventrally located basal plates and in the roof plate ( Fig. 3 e and e'). The basal and alar plates will give rise to motor and sensory neurons respectively, whereas the intermediate horn will give rise to mainly neurons of the autonomic nervous system. On the other hand, the dorsal and ventral midline portions of the spinal cord, known as the roof and floor plates, do not zontain neuroblasts and serve primarily as pathways for nerve fibers.
In the brain, CRABP transcripts present in the mesencephalon were located at the marginal layer (Fig. 3 c and c' and  d and d' ), but transcripts in the myelencephalon and metencephalon were found in the mantle layer ( Fig. 3 b and b' ). CRBP expression in the telencephalon on the other hand, seemed to be confined to its anterior basal portion and to the ependymal and mantle layers (Figs. 3 e and e' -and f and f'), whereas in the myelencephalon, transcripts were detected in the mantle layer (data not shown). Expression of CRABP and CRBP in the CNS is summarized in Table 1. CRABP and CRBP Transcripts Are Present in the Sensory Organs. We have already seen that CRABP was expressed in the frontonasal mass at day 10.5. Later on, at day 12.5, CRABP was still expressed in this area, but by then the nasal chambers had formed and CRABP transcripts were found in the mesenchyme but not in the olfactory epithelium (Fig. 4 b  and b') . Similarly, at 12.5 days, CRBP transcripts were present around the nasolachrymal duct, specifically in the mesenchyme and not in the epithelial cells (data not shown). In the auditory vesicle, CRBP transcripts were found specifically in the mesodermal cells (Fig. 4 e and e'), whereas CRABP transcripts were not detected. In the eye, CRABP and CRBP transcripts were found in the differentiating retinal layer (Fig. 4 a, a', and a") . Furthermore, CRBP was also expressed in the pigmented layer (Fig. 4 d and d') , where vitamin A uptake occurs.
Temporal Expression of CRABP and CRBP Transcripts. To examine any temporal changes of the spatial pattern, we hybridized a series of sections from embryos of different ages: 3.5, 7.5, 8.5, 9.5, 10.5, 11.5, 12.5, and 14.5 days. No hybridization was observed with 3.5-day blastocysts and 7.5-and 8.5-day embryos. In contrast, strong hybridization was observed in 9.5-day embryos with both probes (data not shown).
Thus, at 9.5 days, CRABP is expressed in the telencephalon, mesencephalon, metencephalon, myelencephalon, the spinal cord, and also in the heart bulge. The pattern observed in the spinal cord is similar to the one observed in older embryos (10.5-12.5 days). On the other hand, CRBP seemed to be expressed in many other places than the CNS, such as the gut, the heart, and the liver. In the CNS, labeling with CRBP was seen in the very front end of the telencephalon, in the boundary between the diencephalon and mesencephalon, in the cells surrounding the fourth ventricle, and in the spinal cord. The pattern of expression in the spinal cord at day 9.5 was similar to that observed for older embryos (10.5-12.5 days). It is interesting that both transcripts first appeared at day 9.5, at the time when organogenesis is greatly accelerated and the contour of the embryo is being altered significantly.
The pattern of expression of CRABP and CRBP between 10.5 and 12.5 days has already been described (Figs. 1-4) . At day 14.5, there was still tissue-specific expression of CRABP and CRBP transcripts (data not shown). For CRBP, transcripts are present in the CNS (brain), eyes, liver, heart, lungs, and limbs. For CRABP, there is expression of transcripts in the kidney, liver, lung, CNS, heart, limb, and epidermis. DISCUSSION We have defined the spatial and temporal pattern of expression of CRABP and CRBP during mouse embryogenesis.
The tissue distribution of CRABP and CRBP transcripts that we have found are in good correlation with the spectrum of tissues affected teratogenically by retinoic acid and retinol in embryos of different species (1, (12) (13) (14) (15) (30) (31) (32) (33) (34) . CRABP and CRBP transcripts were found in the limb, spinal cord, brain, and facial structures, which all are well-known teratogenic targets of retinoic acid and retinol. Moreover, this correlation seems to be extended to the level of cell specificity. For example, the mesenchyme of the frontonasal mass rather than the ectoderm is specifically the target of retinoid action in chicken embryos (10) . Again, we found that expression of CRABP transcripts are present in the mesoderm and not in the epithelial cells of the frontonasal mass. Teratogenicity caused by retinoic acid and retinol is strongly dependent on the development stage of the exposed embryos. In the developing limb, Kochhar (31) reported that at earlier stages retinoic acid disrupts cellular activity of the mesenchymal condensations, and at later stages it prevents the enlargement of the condensations that have already appeared. In cleft palate incidence caused by retinoids, Shenefelt (35) reported a correlation between the type of malformation caused by retinoic acid in hamster embryos and the time of treatment. Again, the stages at which we observed CRABP and CRBP expression corresponded well with the stages at which the embryos are susceptible to the teratogenicity of retinoids. Thus, both the spatial and temporal pattern of CRABP and CRBP expression are entirely consistent with the possibility that the teratogenic effects of retinoic acid and retinol are being mediated by CRABP and CRBP.
What are the normal roles of CRABP and CRBP in embryogenesis? We considered it likely that CRABP and CRBP would be involved in the possible morphogenic action of endogenous retinoids. For example in the developing limb, a gradient of retinoic acid has been found along the anteroposterior axis, the highest concentration being on the posterior side, which is the site of the zone of polarizing activity (19) . A reciprocal gradient has been found for CRABP (25) . Maden et al. have proposed that these two gradients would result in a flatter distribution of the retinoic acid-CRABP complex across the limb bud, but in a steeper concentration gradient of free retinoic acid (25) . Thus, free retinoic acid would then act basal and roof plates) +, CNS structures in which CRABP or CRBP transcripts are found. In parentheses are specified the layers of neuroepithelial cells where expression occurs. The inner layer [ependymal (epend.)] is constituted by mitotically dividing neuroepithelial cells, the middle layer (mantle) by nondividing neuroblasts that later will form the gray matter, and the outermost layer (marginal) by nerve fibers emerging from the neuroblasts, which will form the white matter. For the spinal cord, we have additionally indicated the plates that express the transcripts. *Transcripts are expressed at the boundary of these two structures. as a morphogen to alter patterns of gene transcription, by means of the nuclear retinoic acid receptor that is likely to be present at equal concentration throughout the limb (24) . Our findings of CRABP and CRBP expression in the dorsal and ventral areas of the spinal cord, respectively, may point to a similar model for the developing CNS. It is known that the dorsal and ventral areas will acquire sensory and motor characteristics, respectively. The high expression of CRBP in the ventral area may serve to concentrate retinol from the blood stream to this area of the CNS, where retinol will be converted into retinoic acid. Retinoic acid then may form a concentration gradient along the dorsoventral axis, being highest on the ventral side. The gradient of free retinoic acid may be further steepened by the presence of CRABP in the dorsal area, and this gradient may be crucial for the differentiation of sensory and motor neurons. This model can be tested for example by altering the pattern of expression of CRABP and CRBP in the developing CNS of transgenic mice. Regardless of the mechanism of action of CRABP and CRBP, the normal patterns of expression defined here will be useful in future experiments directed at understanding the function of these highly conserved proteins.
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